Calumet, Inc. (NASDAQ:CLMT) Director Sells $754,000.00 in Stock

Calumet, Inc. (NASDAQ:CLMT - Get Free Report) Director Jennifer Straumins sold 50,000 shares of Calumet stock in a transaction on Friday, June 13th. The stock was sold at an average price of $15.08, for a total value of $754,000.00. Following the transaction, the director now directly owns 1,034,589 shares of the company's stock, valued at $15,601,602.12. This trade represents a 4.61% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Jennifer Straumins also recently made the following trade(s):

• On Monday, June 16th, Jennifer Straumins sold 100,000 shares of Calumet stock. The stock was sold at an average price of $16.23, for a total transaction of $1,623,000.00.
• On Thursday, June 5th, Jennifer Straumins sold 100,000 shares of Calumet stock. The stock was sold at an average price of $13.17, for a total transaction of $1,317,000.00.

Calumet Stock Performance

NASDAQ CLMT traded down $0.06 during trading hours on Friday, hitting $16.37. 1,463,834 shares of the company's stock were exchanged, compared to its average volume of 967,974. The business's 50 day moving average is $12.65 and its 200-day moving average is $15.21. Calumet, Inc. has a 12-month low of $7.68 and a 12-month high of $25.29. The firm has a market capitalization of $1.41 billion, a P/E ratio of -4.09 and a beta of 0.91.

Calumet (NASDAQ:CLMT - Get Free Report) last announced its quarterly earnings data on Friday, May 9th. The oil and gas company reported ($1.03) earnings per share for the quarter, missing the consensus estimate of ($0.41) by ($0.62). The firm had revenue of $993.90 million for the quarter, compared to analyst estimates of $899.62 million. During the same quarter in the prior year, the firm posted ($0.51) EPS. Calumet's revenue for the quarter was down 1.2% on a year-over-year basis. As a group, equities research analysts anticipate that Calumet, Inc. will post -3.02 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on the company. UBS Group raised Calumet from a "sell" rating to a "neutral" rating and dropped their price target for the stock from $15.00 to $12.00 in a research report on Monday, March 17th. Bank of America assumed coverage on Calumet in a research report on Tuesday, May 13th. They set a "buy" rating and a $15.00 price objective for the company. HC Wainwright reissued a "buy" rating and issued a $33.00 target price on shares of Calumet in a research note on Monday, March 3rd. The Goldman Sachs Group decreased their price target on shares of Calumet from $16.00 to $14.00 and set a "buy" rating on the stock in a research note on Wednesday, April 30th. Finally, Wells Fargo & Company cut their price objective on shares of Calumet from $23.00 to $21.00 and set an "overweight" rating for the company in a research report on Wednesday, May 14th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and four have issued a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $18.50.

Calumet Company Profile

Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.